Vol. 7, Issue 7 (2018)

Author(s):
Dr. Himani Sharma, Dr. Anamika Sharma

Abstract:
The surface modifications of dental implants have gained an important place in ensuring their long term success. Metformin is one of the first line of drugs for the treatment of type 2 diabetes mellitus. Recent discoveries on the effect of metformin on the proliferation of osteoblast have lead the researchers to use this drug in the cases of periodontitis for enhancing bone formation rendering positive results regarding the bone healing. However, little is known about its effect on the soft tissue. The present article reports its use around dental implants as surface modifying agent, and its associated soft tissue complications.